Denosumab in the treatment of bone metastases
conduct of large multi-center randomized trials in breast, prostate, myeloma and other advanced cancers. In this review, we discuss the development of denosumab, the data that
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
conduct of large multi-center randomized trials in breast, prostate, myeloma and other advanced cancers. In this review, we discuss the development of denosumab, the data that
achieve antitumor responses. Sipuleucel-T is the first immunotherapy approved for asymptomatic, castration-resistant prostate cancer, and while Sipuleucel-T lengthened survival modestly, there was no improvement in time
epithelial-mesenchymal transition (EMT) plays an important role in cancer metastasis. Previous studies have reported that Valproic Acid (VPA) suppresses prostate carcinoma (PCa) cell metastasis and down-regulates SMAD4…
biochemical relapse free survival and the overall survival in both low and intermediate risk prostate cancer patients treated with either intensity modulated radiation therapy (IMRT) alone vs., low dose brachytherapy…
with a number of tumours such as metastatic melanoma as well as breast, colon, prostate and ovarian carcinomas. Typically, nodal can trigger the Smad2/3 intracellular pathways by binding ... nodal signaling represents…
important factor to improve life quality, especially in patients with chronic non-cancer pain. According to the research of the American Geriatrics Society, fibromyalgia syndrome is one of the most ... male had 10 years…
have identified OCT3 as a strong susceptibility gene for coronary artery disease (CAD) and prostate cancer. OCT3 exhibits a broader tissue distribution and is found relatively high-expressed in prostate
levels produced by cancer cells appeared lower when cultured with macrophages. MicroRNA-146a suppresses prostate cancer transformation from androgen-dependent to -independent cells, suppresses a kinase coding gene which…
killing efficacy of CD3+ T cells against EGFR+ colon cancer cells and PSMA+ prostate cancer cells in vitro and in vivo. Contact of BsAb-armed T cells with EGFR
patients from 1st January 2003–30th June 2013 were identified from a prospectively maintained cancer registry. Peri-operative and oncological outcomes were analysed. Significance was defined as p < 0.05. There ... Asia…
activation of osteoclasts, the cells that degrade bone. Src also regulates normal cell functions, cancer cell growth and metastasis to organs, including bone where tumor cells induce bone destruction ... bone disease…
hospitals in Porto, Portugal. The project includes cancer booklets regarding the biomedical and experiential knowledge of breast, lung, colon, esophagus and prostate pathologies. Socio-biographical profile of the…
herein report the anti-cancer activities of some synthesized pyridine derivatives substituted with thiazole, pyrazole and triazole moieties. A series of these derivatives 1-12 were synthesized and evaluated ... rannge…
with the chances of a new fracture higher than the lifetime risk of developing prostate cancer. The mortality associated with hip fractures is higher in men that in women
genome”. p53 gene is mutated in about 50% of human cancers of breast, colon, lung, liver, prostate, bladder, and skin. Since the loss of p53 function is so prevalent
against estrogen dependent breast cancer as well as androgen dependent and independent stages of prostate cancer. Results will summarize what is likely to be the most important natural compounds
Background: AMACR (Alfa-Methylacyl-CoA Racemase) overexpression has become a useful biomarker of prostate cancer. In the present cohort we are aiming to analyse AMACR immunostaining in normal colonic mucosa
emerged as a relevant therapeutic target for the treatment of cancer (e.g. prostate cancer, breast cancer, hematological malignancies, PDAC) and diverse strategies are developed to target CK2, and to synthesize
combined with chromatographic/electrophoretic instrumentation. MS analysis of some glycan changes associated with cancer is quite challenging due to long analysis time, extensive sample pre-treatment/ derivatization and…
Lycopene is a powerful antioxidant that has been linked to a reduced risk of prostate cancer, breast cancer and liver disease/cancer. Studies suggest that curcumin inhibits many of mechanisms ... combination with…
emerged as a relevant therapeutic target for the treatment of cancer (e.g. prostate cancer, breast cancer, hematological malignancies, PDAC) and diverse strategies are developed to target CK2, and to synthesize
anti-cancer efficacy in vitro and in vivo against androgen-dependent and –independent human prostate cancer (PCA) cells via targeting androgen receptor, cell cycle arrest and apoptosis without any toxicity
indicating that the majority or all of those CK-/vimentin+/CD45-cells are circulating prostate cancer cells under epithelial to mesenchymal transition. In addition, the number of CK-/vimentin+/CD45
review, we focus on the differential role of PXR in a variety of cancers, including prostate, breast, ovarian, endometrial, and colon. We also discuss the future directions to further understand
For authors and organisers
Find the right journal for your paper and submit your manuscript.